Literature DB >> 874078

Urinary kallikrein and plasma renin activity as determinants of renal blood flow. The influence of race and dietary sodium intake.

S B Levy, J J Lilley, R P Frigon, R A Stone.   

Abstract

We investigated the relationship of the kallikrein-kinin system and the renin-angiotensin system in the regulation of blood pressure, salt and water excretion, and renal blood flow. Normotensive and hypertensive black and white men were studied during unresticted sodium intake as well as on a 10-meq/day sodium intake; potassium intake was held constant throughout the study (80 meq/day). During unrestricted sodium intake, urinary kallikrein activity was greater in white normotensives than white hypertensives or black normotensives. There was no difference (P greater than 0.05) between white and black hypertensives or between black normotensives and black hypertensives. All groups had greater urinary kallikrein activity on low sodium vs. unrestricted sodium intake, but the increase in black hypertensives was small, and they excreted significantly less kallikrein than the ogher groups on the low sodium diet. Plasma renin activity showed similar increments after sodium restriction in all groups. Urinary kallikrein activity correlated with renal blood flow in all groups except the black normotensives on low sodium intake. Renal blood flow could be correlated uniformly with log (urinary kallikrein activity/supine plasma renin activity) in all groups on either diet. Urinary sodium and potassium excretion and urine volume were not different among the groups. We conclude: (a) important racial differences exist in urinary kallikrein activity that are unrelated to sodium or potassium excretion or urine volume; (b) dietary sodium restriction further delineates racial differences and suggests alternative pathophysiologic mechanisms for huma hypertension; (c) urinary kallikrein activity correlates with renal blood flow; and (d) our data support the concept that the kallikrein-kinin system and the renin-angiotensin system contribute to the regulation of renal blood flow and may account for racial differences in renal vascular resistance.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 874078      PMCID: PMC372351          DOI: 10.1172/JCI108749

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  33 in total

1.  Erythrocyte glucose-6-phosphate dehydrogenase deficiency: evidence of differences between Negroes and Caucasians with respect to this genetically determined trait.

Authors:  P A MARKS; R T GROSS
Journal:  J Clin Invest       Date:  1959-12       Impact factor: 14.808

2.  Measurement of the rate of plasmin action on synthetic substrates.

Authors:  P S ROBERTS
Journal:  J Biol Chem       Date:  1958-05       Impact factor: 5.157

3.  Stimulated renin: a screening test for hypertension.

Authors:  L Wallach; I Nyarai; K G Dawson
Journal:  Ann Intern Med       Date:  1975-01       Impact factor: 25.391

Review 4.  Formation of human plasma kinin.

Authors:  R W Colman
Journal:  N Engl J Med       Date:  1974-09-05       Impact factor: 91.245

5.  Urinary kallikrein excretion in hypertensive man. Relationships to sodium intake and sodium-retaining steroids.

Authors:  H S Margolius; D Horwitz; J J Pisano; H R Keiser
Journal:  Circ Res       Date:  1974-12       Impact factor: 17.367

6.  Urinary kallikrein excretion in normal man. Relationships to sodium intake and sodium-retaining steroids.

Authors:  H S Margolius; D Horwitz; R G Geller; R W Alexander; J R Gill; J J Pisano; H R Keiser
Journal:  Circ Res       Date:  1974-12       Impact factor: 17.367

7.  Purification and properties of a human urinary kallikrein (kininogenase).

Authors:  V Hial; C R Diniz; M Mares-Guia
Journal:  Biochemistry       Date:  1974-10-08       Impact factor: 3.162

8.  Renal tissue kallikrein, plasma renin and plasma aldosterone in renal hypertension.

Authors:  O A Carretero; N B Oza; A G Scigli; A Schork
Journal:  Acta Physiol Lat Am       Date:  1974

9.  Urinary kallikrein excretion in hypertension.

Authors:  H S Margolius; R G Geller; W De Jong; J J Pisano; A Sjoerdsma
Journal:  Circ Res       Date:  1972-09       Impact factor: 17.367

10.  The relationship between kidney and urinary kininogenase.

Authors:  K Nustad
Journal:  Br J Pharmacol       Date:  1970-05       Impact factor: 8.739

View more
  32 in total

Review 1.  The renin-angiotensin system in blacks: active, passive, or what?

Authors:  Deborah A Price; Naomi D L Fisher
Journal:  Curr Hypertens Rep       Date:  2003-06       Impact factor: 5.369

Review 2.  Tissue kallikreins structure, regulation, and participation in mammalian physiology and disease.

Authors:  H S Margolius
Journal:  Clin Rev Allergy Immunol       Date:  1998       Impact factor: 8.667

Review 3.  Essential hypertension in blacks: epidemiology, characteristics, and possible roles of racial differences in sodium, potassium, and calcium regulation.

Authors:  A Aviv; M Aladjem
Journal:  Cardiovasc Drugs Ther       Date:  1990-03       Impact factor: 3.727

Review 4.  Cyclosporine and rheumatoid arthritis.

Authors:  O Førre; K Waalen; H E Rugstad; K J Berg; D Solbu; E Kåss
Journal:  Springer Semin Immunopathol       Date:  1988

5.  Race, plasma renin activity, and morning blood pressure surge--results from the Dietary Approaches to Stop Hypertension trial.

Authors:  Finnian R Mc Causland; Ciaran J McMullan; Frank M Sacks; John P Forman
Journal:  Am J Hypertens       Date:  2013-03-08       Impact factor: 2.689

6.  Prazosin depression of baroreflex function in hypertensive man.

Authors:  E H Sasso; D T O'Connor
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

7.  Association of renin and aldosterone with ethnicity and blood pressure: the Multi-Ethnic Study of Atherosclerosis.

Authors:  Dena E Rifkin; Ali R Khaki; Nancy S Jenny; Robyn L McClelland; Matthew Budoff; Karol Watson; Joachim H Ix; Matthew A Allison
Journal:  Am J Hypertens       Date:  2014-01-16       Impact factor: 2.689

8.  Impaired renal kallikrein activity and elevated blood pressure normalized by orally applied kallikrein in essential hypertension.

Authors:  K O Stumpe; A Overlack; C Ressel; F Krück
Journal:  Agents Actions       Date:  1980-09

9.  Decreased urinary kallikrein activity and elevated blood pressure normalized by orally applied kallikrein in essential hypertension.

Authors:  A Overlack; K O Stumpe; C Ressel; R Kolloch; W Zywzok; F Krück
Journal:  Klin Wochenschr       Date:  1980-01-02

10.  Kallikrein along the rabbit microdissected nephron: a micromethod for its measurement. Effect of adrenalectomy and DOCA treatment.

Authors:  J Marchetti; M Imbert-Teboul; F Alhenc-Gelas; J Allegrini; J Menard; F Morel
Journal:  Pflugers Arch       Date:  1984-05       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.